Unknown

Dataset Information

0

Characterization of the major histocompatibility complex class II binding site on LAG-3 protein.


ABSTRACT: The lymphocyte activation gene-3 (LAG-3), selectively transcribed in human activated T and NK cells, encodes a ligand for major histocompatibility complex (MHC) class II molecules. Like CD4, LAG-3 ectodomain is composed of four Ig-like domains (D1-D4). Nothing is known about the LAG-3 regions or residues required to form a stable MHC class II binding site. In contrast to CD4, soluble LAG-3 molecules stably interact with MHC class II molecules expressed on the cell surface. In addition, the first two N-terminal domains of soluble LAG-3 (D1 and D2) molecules, alone, are capable of binding MHC class II. From a LAG-3 model structure, we designed mutants and tested their ability to bind MHC class II molecules in an intercellular adhesion assay. We found residues on the membrane-distal, CDR1-2-containing top face of D1 that are essential for either binding or repulsing MHC class II proteins. Most of these residues are clustered at the base of a large extra-loop structure that is a hallmark of the LAG-3 D1 Ig-like domain. In addition, as for CD4, oligomerization of LAG-3 on the cell surface may be required to form a stable MHC binding site because mutation of three residues in the ABED beta-strands containing side of D1 results in a dominant negative effect (i.e., binding inhibition of coexpressed wild-type LAG-3).

SUBMITTER: Huard B 

PROVIDER: S-EPMC20850 | biostudies-literature | 1997 May

REPOSITORIES: biostudies-literature

altmetric image

Publications

Characterization of the major histocompatibility complex class II binding site on LAG-3 protein.

Huard B B   Mastrangeli R R   Prigent P P   Bruniquel D D   Donini S S   El-Tayar N N   Maigret B B   Dréano M M   Triebel F F  

Proceedings of the National Academy of Sciences of the United States of America 19970501 11


The lymphocyte activation gene-3 (LAG-3), selectively transcribed in human activated T and NK cells, encodes a ligand for major histocompatibility complex (MHC) class II molecules. Like CD4, LAG-3 ectodomain is composed of four Ig-like domains (D1-D4). Nothing is known about the LAG-3 regions or residues required to form a stable MHC class II binding site. In contrast to CD4, soluble LAG-3 molecules stably interact with MHC class II molecules expressed on the cell surface. In addition, the first  ...[more]

Similar Datasets

| PRJNA862637 | ENA
| S-EPMC3162010 | biostudies-literature
| S-EPMC6459222 | biostudies-literature
| S-EPMC3209250 | biostudies-literature
| S-EPMC4878507 | biostudies-literature
| S-EPMC50662 | biostudies-other
| S-EPMC18298 | biostudies-literature
| S-EPMC114676 | biostudies-literature
2017-03-15 | GSE90474 | GEO
| S-EPMC2423261 | biostudies-literature